Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Metabolites
|
April 30, 2021
Metabolite Profile of Treatment-Naive Metabolic Syndrome Subjects in Relation to Cardiovascular Disease Risk
Moritz V Warmbrunn, Annefleur M Koopen, Nicolien C de Clercq, et al.
Gut Microbes
|
July 4, 2024
Oral histidine affects gut microbiota and MAIT cells improving glycemic control in type 2 diabetes patients
Moritz V Warmbrunn, Ilias Attaye, Judith Aron-Wisnewsky, et al.
Cardiovascular Research
|
January 30, 2024
Networks of gut bacteria relate to cardiovascular disease in a multi-ethnic population: the HELIUS study
Moritz V Warmbrunn, Ulrika Boulund, Judith Aron-Wisnewsky, et al.
NPJ Biofilms and Microbiomes
|
November 4, 2024
Kinetics of imidazole propionate from orally delivered histidine in mice and humans
Moritz V Warmbrunn, Ilias Attaye, Anthony Horak, et al.
Scientific Reports
|
March 31, 2022
Genetic and phenotypic diversity of fecal Candida albicans strains in irritable bowel syndrome
Isabelle A M van Thiel, Aimilia A Stavrou, Auke de Jong, et al.
Nutrients
|
June 27, 2024
Novel Proteome Targets Marking Insulin Resistance in Metabolic Syndrome
Moritz V Warmbrunn, Harsh Bahrar, Nicolien C de Clercq, et al.
Plos One
|
July 5, 2013
Genome analysis and physiological comparison of Alicycliphilus denitrificans strains BC and K601(T.)
Margreet J Oosterkamp, Teun Veuskens, Flávia Talarico Saia, et al.
Nature Medicine
|
October 10, 2022
Microbiome-derived ethanol in nonalcoholic fatty liver disease
Abraham S Meijnikman, Mark Davids, Hilde Herrema, et al.
Diabetologia
|
January 10, 2020
Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trial
Pieter F de Groot, Tatjana Nikolic, Sultan Imangaliyev, et al.
Gut Microbes
|
August 19, 2022
Gut-derived bacterial flagellin induces beta-cell inflammation and dysfunction
Torsten P M Scheithauer, Hilde Herrema, Hongbing Yu, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Metabolites
|
April 30, 2021
Metabolite Profile of Treatment-Naive Metabolic Syndrome Subjects in Relation to Cardiovascular Disease Risk
Moritz V Warmbrunn, Annefleur M Koopen, Nicolien C de Clercq, et al.
Gut Microbes
|
July 4, 2024
Oral histidine affects gut microbiota and MAIT cells improving glycemic control in type 2 diabetes patients
Moritz V Warmbrunn, Ilias Attaye, Judith Aron-Wisnewsky, et al.
Cardiovascular Research
|
January 30, 2024
Networks of gut bacteria relate to cardiovascular disease in a multi-ethnic population: the HELIUS study
Moritz V Warmbrunn, Ulrika Boulund, Judith Aron-Wisnewsky, et al.
NPJ Biofilms and Microbiomes
|
November 4, 2024
Kinetics of imidazole propionate from orally delivered histidine in mice and humans
Moritz V Warmbrunn, Ilias Attaye, Anthony Horak, et al.
Scientific Reports
|
March 31, 2022
Genetic and phenotypic diversity of fecal Candida albicans strains in irritable bowel syndrome
Isabelle A M van Thiel, Aimilia A Stavrou, Auke de Jong, et al.
Nutrients
|
June 27, 2024
Novel Proteome Targets Marking Insulin Resistance in Metabolic Syndrome
Moritz V Warmbrunn, Harsh Bahrar, Nicolien C de Clercq, et al.
Plos One
|
July 5, 2013
Genome analysis and physiological comparison of Alicycliphilus denitrificans strains BC and K601(T.)
Margreet J Oosterkamp, Teun Veuskens, Flávia Talarico Saia, et al.
Nature Medicine
|
October 10, 2022
Microbiome-derived ethanol in nonalcoholic fatty liver disease
Abraham S Meijnikman, Mark Davids, Hilde Herrema, et al.
Diabetologia
|
January 10, 2020
Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trial
Pieter F de Groot, Tatjana Nikolic, Sultan Imangaliyev, et al.
Gut Microbes
|
August 19, 2022
Gut-derived bacterial flagellin induces beta-cell inflammation and dysfunction
Torsten P M Scheithauer, Hilde Herrema, Hongbing Yu, et al.
Page
of 7